Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ORASURE TECHNOLOGIES, INC (OSUR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ORASURE TECHNOLOGIES, INC (OSUR), most recent 12 months reported: revenue $112.41M, net loss $49.13M, free cash flow -$48.06M. Latest balance sheet on file: liquid cash $160.58M. From SEC filings. Others in Surgical & Medical Instruments & Apparatus: Neuronetics, Inc. · INFUSYSTEM HOLDINGS, INC · Anika Therapeutics, Inc. · Beta Bionics, Inc. · XTANT MEDICAL HOLDINGS, INC. · Kestra Medical Technologies, Ltd. · NEUROPACE, INC. · DELCATH SYSTEMS, INC.

Stock screener

Watchlist